Engineers Gate Manager’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$349K Buy
+11,761
New +$337K ﹤0.01% 1727
2025
Q3
– Sell
-19,990
Closed -$560K – 2296
2025
Q2
$560K Buy
+19,990
New +$536K 0.01% 1425
2023
Q3
– Sell
-5,574
Closed -$227K – 1905
2023
Q2
$227K Buy
+5,574
New +$227K 0.01% 1430
2020
Q3
– Sell
-1,230
Closed -$243K – 1793
2020
Q2
$243K Sell
1,230
-310
-20% -$64.2K 0.01% 1331
2020
Q1
$302K Buy
+1,540
New +$331K 0.02% 1037

Other funds holding LKFT

Engineers Gate Manager's LKFT Position: Q3 2026 in Review

Engineers Gate Manager opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 11,761 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #1727 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in LKFT as recently as Q2 2025.

Engineers Gate Manager first reported a position in LKFT in Q1 2020 and has held it in 5 quarters since. The position peaked at $560K in Q2 2025. 95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Engineers Gate Manager held 11,761 shares of Lakefront Biotherapeutics American Depositary Shares worth $349K as of Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Engineers Gate Manager position in Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Engineers Gate Manager's portfolio in Q3 2026, its #1727 holding.
  • Engineers Gate Manager first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and has held it in 5 quarters since.
  • Engineers Gate Manager's Lakefront Biotherapeutics American Depositary Shares position peaked at $560K in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Engineers Gate Manager's 13F filing for Q3 2026, filed 16 Nov 2026.